Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes

PURPOSE: Intravitreal antivascular endothelial growth factor (anti-VEGF) application has revolutionized the treatment of choroidal neovascularization (CNV), a hallmark of wet age-related macular degeneration. However, additional treatment options are desirable as not all CNV lesions respond to anti-...

Descripción completa

Detalles Bibliográficos
Autores principales: Gross, Nikolai, Ranjbar, Mahdy, Evers, Charlotte, Hua, Jing, Martin, Gottfried, Schulze, Brita, Michaelis, Uwe, Hansen, Lutz L., Agostini, Hansjürgen T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548578/
https://www.ncbi.nlm.nih.gov/pubmed/23335851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548578/
https://www.ncbi.nlm.nih.gov/pubmed/23335851

Ejemplares similares